Oral Hygiene and Maternity Outcomes Multicenter Study (OHMOM)

NCT ID: NCT01549587

Last Updated: 2023-04-21

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

746 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-02-29

Study Completion Date

2014-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will track changes in oral health in pregnant women. Subjects will be assigned to either regular oral care or advanced oral care and be given oral care products to use until they deliver. A comparison between the two groups (regular and advanced oral care) will be made to see if the oral care products impacted oral health and maternity variables.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gingivitis Pregnancy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Regular Oral Hygiene

toothpaste, toothbrush and dental floss

Group Type ACTIVE_COMPARATOR

0.243% sodium fluoride

Intervention Type DRUG

dentifrice: brush thoroughly twice daily

toothbrush

Intervention Type DEVICE

brush thoroughly twice daily

dental floss

Intervention Type DEVICE

floss the whole mouth once daily

Advanced Oral Hygiene plus counseling

toothpaste, toothbrush, mouth rinse and dental floss plus specialized education

Group Type EXPERIMENTAL

0.454% stannous fluoride

Intervention Type DRUG

dentifrice: twice daily brush thoroughly for 2 minutes

toothbrush

Intervention Type DEVICE

twice daily brush thoroughly for 2 minutes

0.07% Cetylpyridinium chloride

Intervention Type DRUG

mouth rinse: rinse with 20 mL of mouth rinse for 30 seconds twice daily

dental floss

Intervention Type DEVICE

floss the whole mouth once daily

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

0.243% sodium fluoride

dentifrice: brush thoroughly twice daily

Intervention Type DRUG

toothbrush

brush thoroughly twice daily

Intervention Type DEVICE

dental floss

floss the whole mouth once daily

Intervention Type DEVICE

0.454% stannous fluoride

dentifrice: twice daily brush thoroughly for 2 minutes

Intervention Type DRUG

toothbrush

twice daily brush thoroughly for 2 minutes

Intervention Type DEVICE

0.07% Cetylpyridinium chloride

mouth rinse: rinse with 20 mL of mouth rinse for 30 seconds twice daily

Intervention Type DRUG

dental floss

floss the whole mouth once daily

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Crest® Cavity Protection toothpaste Oral-B® Indicator toothbrush, regular, soft Oral-B® Essentials dental floss Crest® Pro-Health toothpaste Oral-B® ProfessionalCare Series 1000 toothbrush, Oral-B® Precision Clean brush head Crest® Pro-Health Multi-Protection Mouth Rinse Glide® Pro-Health Deep Clean dental floss

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* provide written informed consent prior to participation and be given a signed copy of the informed consent form;
* be at least the age of legal consent;
* be between 8 and 24 weeks of pregnancy;
* have at least 20 natural teeth;
* have moderate-to-severe gingivitis during pregnancy, including at least 30 intraoral sites with evidence of marginal gingival bleeding.

Exclusion Criteria

* evidence of multiple gestations;
* history of HIV infection, AIDS, autoimmune disease, or diabetes other than gestational diabetes;
* indication for use of antibiotic pre-medication prior to dental procedures;
* systemic corticosteroid or immunosuppressive therapy within 1 month of Baseline;
* severe periodontal disease, rampant untreated dental caries, or other oral conditions that necessitate immediate dental care;
* ongoing dental care that in the opinion of the investigator could impact study participation;
* a history of allergies or hypersensitivity to mouth rinse products containing CPC;
* any disease or condition that in the opinion of the investigator could interfere with the safe completion of the study;
* randomization to a treatment in study 2011001 during a prior pregnancy.
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Procter and Gamble

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Marjorie Jeffcoat, DMD

Role: PRINCIPAL_INVESTIGATOR

School of Dentistry University of Pennsylvania

Michael Reddy, DMD, DMSc

Role: PRINCIPAL_INVESTIGATOR

School of Dentistry University of Alabama

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Center for Women's Reproductive Health

Birmingham, Alabama, United States

Site Status

Penn OB/Gyn and Associates

Philadelphia, Pennsylvania, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Parry S, Jeffcoat M, Reddy MS, Doyle MJ, Grender JM, Gerlach RW, Tanna N, Geisinger ML, Geurs NC, Biggio J. Evaluation of an advanced oral hygiene regimen on maternity outcomes in a randomized multicenter clinical trial (Oral Hygiene and Maternity Outcomes Multicenter Study). Am J Obstet Gynecol MFM. 2023 Aug;5(8):100995. doi: 10.1016/j.ajogmf.2023.100995. Epub 2023 Apr 29.

Reference Type DERIVED
PMID: 37127210 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Document Type: Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2011001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

A Study of Experimental Mouthwashes
NCT05121909 COMPLETED PHASE4